Rajnath Singh urges Aatmanirbharta 2.0 in defence, boosting advanced tech, private R&D, and resilient domestic supply chains for strategic autonomy.
The issuance of Common Shares was approved by the TSX Venture Exchange (the "TSXV") on October 5, 2026.
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results